Nanomedicines Market, By Modality (Treatment and Diagnostics), By Application, By Indication, By Molecule Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Nanomedicines Market size was valued at USD 231.04 Million in 2023, expanding at a CAGR of 12.92% from 2024 to 2032.
The nanomedicine market encompasses the use of nanotechnology for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications. The development of personalized nanomedicines tailored to individual patient profiles, and increasing research focus on combination therapies and multifunctional nanoplatforms. However, restraints in the nanomedicine market include challenges related to regulatory approvals and safety concerns associated with nanomaterials. Opportunities abound in the integration of nanotechnology with other emerging technologies like artificial intelligence and gene editing for precision medicine approaches.
Nanomedicines Market- Market Dynamics
Ø Rapidly increasing utilization of nanotechnology in drug delivery methods to propel market demand
The adoption of nanotechnology-based methods for drug delivery is experiencing rapid growth, driven by the advantages offered in terms of targeted delivery, enhanced drug efficacy, and reduced side effects. This growth is fueled by increasing investments in research and development, advancements in nanomaterials and drug delivery technologies, and a rising demand for personalized and precision medicine solutions. Additionally, the COVID-19 pandemic has further accelerated the adoption of nanotechnology in drug delivery, with the development of nanomedicine-based vaccines and therapeutics to combat the virus.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NANOMEDICINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø Sanofi SA
Ø Celgene Corporation
Ø Nanobiotix
Ø Luminex Corporation
Ø Nanospectra Biosciences Inc
Ø NanoCarrier Co. Ltd
Ø Johnson & Johnson Services Inc
Ø Merck & Co., Inc
Ø Pfizer, Inc.
Ø NanoCarrier Co. Ltd
Ø Taiwan Liposome Company Ltd
Ø Hoffmann-La Roche AG (Roche)
Ø Gilead Science Inc
Ø Ipsen SA.
Ø Others
GLOBAL NANOMEDICINES MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032
Ø Treatment
Ø Diagnostics
GLOBAL NANOMEDICINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Ø Drug Delivery
Ø IVD
Ø Implant
Ø Vaccine
Ø Others
GLOBAL NANOMEDICINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
Ø Oncology
Ø Infectious
Ø Cardiovascular
Ø Neurological
GLOBAL NANOMEDICINES MARKET, BY MOLECULE TYPE- MARKET ANALYSIS, 2019 - 2032
Ø Nanoparticle
Ø Nanotube
Ø Nanodevice
GLOBAL NANOMEDICINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o The U.S.
o Canada
Ø Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Ø Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Nanomedicines Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Nanomedicines Market Snippet by Modality
2.1.2. Nanomedicines Market Snippet by Application
2.1.3. Nanomedicines Market Snippet by Indication
2.1.4. Nanomedicines Market Snippet by Molecule Type
2.1.5. Nanomedicines Market Snippet by Country
2.1.6. Nanomedicines Market Snippet by Region
2.2. Competitive Insights
3. Nanomedicines Key Market Trends
3.1. Nanomedicines Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Nanomedicines Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Nanomedicines Market Opportunities
3.4. Nanomedicines Market Future Trends
4. Nanomedicines Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Nanomedicines Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Nanomedicines Market Landscape
6.1. Nanomedicines Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Nanomedicines Market – By Modality
7.1. Overview
7.1.1. Segment Share Analysis, By Modality, 2023 & 2032 (%)
7.1.2. Treatment
7.1.3. Diagnostics
8. Nanomedicines Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
8.1.2. Drug Delivery
8.1.3. IVD
8.1.4. Implant
8.1.5. Vaccine
8.1.6. Others
9. Nanomedicines Market – By Indication
9.1. Overview
9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
9.1.2. Oncology
9.1.3. Infectious
9.1.4. Cardiovascular
9.1.5. Neurological
10. Nanomedicines Market – By Molecule Type
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
10.1.2. Nanoparticle
10.1.3. Nanotube
10.1.4. Nanodevice
11. Nanomedicines Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Nanomedicines Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Nanomedicines Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Nanomedicines Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Nanomedicines Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Nanomedicines Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Nanomedicines Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Sanofi SA
12.2.2. Celgene Corporation
12.2.3. Nanobiotix
12.2.4. Luminex Corporation
12.2.5. Nanospectra Biosciences Inc
12.2.6. NanoCarrier Co. Ltd
12.2.7. Johnson & Johnson Services Inc
12.2.8. Merck & Co., Inc
12.2.9. Pfizer, Inc.
12.2.10. NanoCarrier Co. Ltd
12.2.11. Taiwan Liposome Company Ltd
12.2.12. Hoffmann-La Roche AG (Roche)
12.2.13. Gilead Science Inc
12.2.14. Ipsen SA.
12.2.15. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
